NO20030762D0 - Forbedret spesifisitet i behandling av sykdommer - Google Patents

Forbedret spesifisitet i behandling av sykdommer

Info

Publication number
NO20030762D0
NO20030762D0 NO20030762A NO20030762A NO20030762D0 NO 20030762 D0 NO20030762 D0 NO 20030762D0 NO 20030762 A NO20030762 A NO 20030762A NO 20030762 A NO20030762 A NO 20030762A NO 20030762 D0 NO20030762 D0 NO 20030762D0
Authority
NO
Norway
Prior art keywords
diseases
treatment
improved specificity
specificity
improved
Prior art date
Application number
NO20030762A
Other languages
English (en)
Other versions
NO20030762L (no
Inventor
Johnson Lau
Zhi Hong
Chin-Chung Lin
Original Assignee
Ribapharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribapharm Inc filed Critical Ribapharm Inc
Publication of NO20030762D0 publication Critical patent/NO20030762D0/no
Publication of NO20030762L publication Critical patent/NO20030762L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20030762A 2000-08-22 2003-02-18 Forbedret spesifisitet i behandling av sykdommer NO20030762L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US22687000P 2000-08-22 2000-08-22
US22694800P 2000-08-22 2000-08-22
US22687100P 2000-08-22 2000-08-22
PCT/US2000/033454 WO2002016382A1 (en) 2000-08-22 2000-12-07 Improved specificity in treatment of diseases

Publications (2)

Publication Number Publication Date
NO20030762D0 true NO20030762D0 (no) 2003-02-18
NO20030762L NO20030762L (no) 2003-04-22

Family

ID=27397667

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030762A NO20030762L (no) 2000-08-22 2003-02-18 Forbedret spesifisitet i behandling av sykdommer

Country Status (15)

Country Link
EP (1) EP1351966A1 (no)
JP (1) JP2004518618A (no)
KR (1) KR20030040415A (no)
CN (1) CN1460109A (no)
AU (1) AU2001220806A1 (no)
BR (1) BR0017318A (no)
CA (1) CA2416748A1 (no)
CZ (1) CZ2003460A3 (no)
HU (1) HUP0302882A3 (no)
IL (1) IL154168A0 (no)
MX (1) MXPA03001528A (no)
NO (1) NO20030762L (no)
PL (1) PL365879A1 (no)
TW (1) TW200414903A (no)
WO (1) WO2002016382A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
US20050182252A1 (en) 2004-02-13 2005-08-18 Reddy K. R. Novel 2'-C-methyl nucleoside derivatives
CN100448879C (zh) * 2004-07-22 2009-01-07 北京化工大学 一种无定型头孢呋辛酯的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3798209A (en) * 1971-06-01 1974-03-19 Icn Pharmaceuticals 1,2,4-triazole nucleosides
US3991078A (en) * 1971-06-01 1976-11-09 Icn Pharmaceuticals, Inc. N-substituted 1,2,4-triazoles
US3984396A (en) * 1971-06-01 1976-10-05 Icn Pharmaceuticals, Inc. 1-(β,-D-ribofuranosyl)-1,2,4-triazole acid esters
USRE29835E (en) * 1971-06-01 1978-11-14 Icn Pharmaceuticals 1,2,4-Triazole nucleosides
US4093624A (en) * 1977-01-31 1978-06-06 Icn Pharmaceuticals, Inc. 1,2,4-Thiadiazolidine-3,5-dione
JPS6426593A (en) * 1987-07-21 1989-01-27 Asahi Glass Co Ltd Nucleoside derivative
US4925930A (en) * 1988-11-02 1990-05-15 Nucleic Acid Research Institute Synthesis and anti-leukemic activity of alkyl-1-(β-D-ribofuranosyl)[1,2,4]triazole-3-carboximidates

Also Published As

Publication number Publication date
CN1460109A (zh) 2003-12-03
PL365879A1 (en) 2005-01-10
WO2002016382A1 (en) 2002-02-28
AU2001220806A1 (en) 2002-03-04
HUP0302882A3 (en) 2005-06-28
MXPA03001528A (es) 2004-04-02
EP1351966A1 (en) 2003-10-15
CA2416748A1 (en) 2002-02-28
JP2004518618A (ja) 2004-06-24
BR0017318A (pt) 2004-06-15
NO20030762L (no) 2003-04-22
TW200414903A (en) 2004-08-16
IL154168A0 (en) 2003-07-31
HUP0302882A2 (hu) 2003-12-29
CZ2003460A3 (cs) 2003-10-15
KR20030040415A (ko) 2003-05-22

Similar Documents

Publication Publication Date Title
NO20024273L (no) Terapeutiske anvendelser av PPAR-mediatorer
NO20031442L (no) Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
MXPA03002813A (es) Compuestos utiles en el tratamiento de enfermedades inflamatorias.
ATE472325T1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
FIU20060389U0 (fi) Luusairauksien hoito
NO20026008L (no) Fremgangsmåte for behandling av cardiovaskul¶re sykdommer
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20032122D0 (no) Forbedret behandling
DE60136477D1 (de) Retinoide zur behandlung von emphysem
NO20024486L (no) Forbedret behandling av neovaskularisering
ID27576A (id) Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
NO20024777L (no) Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
NO20024776L (no) Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
NO20024236D0 (no) Behandling av psoriasis
DE60103685D1 (de) Behandlung von Poriomania
NO20023803D0 (no) Anvendelse av mirtazapin for behandling av sövnforstyrrelser
NO20030762D0 (no) Forbedret spesifisitet i behandling av sykdommer
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
ID30458A (id) Osanetan dalam pengobatan gangguan jiwa
SE0300535L (sv) Behandling av brännskador
DE60125035D1 (de) Behandlung von plasmid-haltigen lösungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application